Liminal BioSciences Inc.
LMNL · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,141 | -$7,432 | -$4,244 | $22,255 |
| Dep. & Amort. | $233 | $250 | $283 | $274 |
| Deferred Tax | -$36 | $0 | $0 | $0 |
| Stock-Based Comp. | $243 | $287 | $295 | $413 |
| Change in WC | $857 | $139 | -$842 | -$1,715 |
| Other Non-Cash | $65 | -$3,586 | -$1,791 | -$32,925 |
| Operating Cash Flow | -$7,779 | -$10,342 | -$6,299 | -$11,698 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $19 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $3,447 | $230 |
| Investing Cash Flow | $335 | $342 | $3,466 | $227 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$202 | -$204 | -$199 | -$5,692 |
| Financing Cash Flow | -$202 | -$204 | -$199 | -$5,692 |
| Forex Effect | $16 | $2 | -$576 | $2,110 |
| Net Chg. in Cash | -$7,630 | -$10,202 | -$3,608 | -$15,053 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26,942 | $37,144 | $40,752 | $55,805 |
| End Cash | $19,312 | $26,942 | $37,144 | $40,752 |
| Free Cash Flow | -$7,779 | -$10,342 | -$6,280 | -$11,701 |